Caitlin Elizabeth Kalinowski Sells 450 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) Stock

Axon Enterprise, Inc. (NASDAQ:AXON) Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON opened at $601.06 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $241.72 and a 1-year high of $698.67. The stock has a market capitalization of $45.83 billion, a P/E ratio of 155.31, a P/E/G ratio of 14.19 and a beta of 1.01. The business has a 50-day moving average price of $593.68 and a two-hundred day moving average price of $439.15.

Institutional Investors Weigh In On Axon Enterprise

Institutional investors have recently modified their holdings of the business. Concurrent Investment Advisors LLC boosted its stake in Axon Enterprise by 15.5% in the second quarter. Concurrent Investment Advisors LLC now owns 796 shares of the biotechnology company’s stock valued at $234,000 after acquiring an additional 107 shares during the last quarter. D.A. Davidson & CO. boosted its position in shares of Axon Enterprise by 2.2% in the 2nd quarter. D.A. Davidson & CO. now owns 12,578 shares of the biotechnology company’s stock worth $3,701,000 after purchasing an additional 273 shares during the last quarter. Natixis Advisors LLC grew its stake in shares of Axon Enterprise by 12.6% during the second quarter. Natixis Advisors LLC now owns 28,840 shares of the biotechnology company’s stock worth $8,486,000 after purchasing an additional 3,229 shares during the period. CIBC Asset Management Inc increased its holdings in Axon Enterprise by 0.8% in the second quarter. CIBC Asset Management Inc now owns 9,683 shares of the biotechnology company’s stock valued at $2,849,000 after purchasing an additional 79 shares during the last quarter. Finally, Rhumbline Advisers lifted its stake in Axon Enterprise by 1.5% in the second quarter. Rhumbline Advisers now owns 150,700 shares of the biotechnology company’s stock valued at $44,342,000 after buying an additional 2,292 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on AXON. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Finally, JMP Securities boosted their price objective on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $488.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.